ArvinasvsJohnson & Johnson

ARVN and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

Arvinas (ARVN) has a market value of $426M and Johnson & Johnson (JNJ) $644B. Over the last year, with dividends, ARVN moved -48.7% and JNJ +36.6%. Dividend yield: ARVN none, JNJ 1.98%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ARVN$426M

    JNJ$644B

    JNJ is 1,511 times ARVN

  • Revenue, 12 months

    ARVN$275M

    JNJ$99.3B

    JNJ is 361 times ARVN

  • Net income, 12 months

    ARVN-$9.5M

    JNJ$16.1B

  • Operating margin

    ARVN-12.1%

    JNJ–

  • ROIC

    ARVN-5.4%

    JNJ12.4%

    17.7 points apart

  • P/E

    ARVN–

    JNJ40.0

  • Dividend yield

    ARVN0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    ARVN-91.6%

    JNJ+89.1%

    180.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ARVN-91.6%

JNJ+89.1%

010020020222023202420252026
Returns by period
PeriodARVNWith dividendsJNJWith dividends
1 year since November 18, 2025-48.7%Price -48.7%+36.6%Price +33.6%
3 years since November 17, 2023-68.2%-31.7% a yearPrice -68.2%+94.2%+24.8% a yearPrice +78.4%
5 years since November 18, 2021-91.6%-39.0% a yearPrice -91.6%+89.1%+13.6% a yearPrice +64.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ARVNArvinasJNJJohnson & Johnson

Valuation

ARVNJNJ
Valuation
Price$6.66$267.06
Market value$426M$644B
Enterprise value (EV)–$671B
P/E–40.0
P/E, 5-year median–21.9
P/B0.87.9
EV/EBIT–37.8
Free cash flow yield–3.2%

Results and growth

ARVNJNJ
Results and growth
Revenue, 12 months$275M$99.3B
Net income, 12 months-$9.5M$16.1B
Free cash flow, 12 months-$160M$20.6B
Earnings per share, 12 months-$0.10$6.59
Revenue growth, year on year-0.3%6.1%
Revenue growth a year, past+58.9%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

ARVNJNJ
Margins and returns on capital
Gross margin–67.6%
Operating margin-12.1%–
Net margin-3.5%16.2%
ROIC-5.4%12.4%
ROE-1.9%19.7%

Balance sheet

ARVNJNJ
Balance sheet
Cash$558M$17.2B
Total debt$7.6M$44.7B
Net debt / EBITDA–1.1
Interest cover–18.0×

Dividends and buybacks

ARVNJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield21.6%0.9%
Shareholder yield21.6%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ARVN or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Arvinas or Johnson & Johnson?

By market value, Johnson & Johnson ($644B) is about 1,510.9 times Arvinas ($426M), at today's prices.

How did ARVN and JNJ stock do over the last 5 years?

Since November 18, 2021, ARVN's price moved -91.6% and JNJ's +64.5%. With dividends: ARVN -91.6% (-39.0% a year), JNJ +89.1% (+13.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, ARVN or JNJ?

The dividend yield at today's price is none for Arvinas and 1.98% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, Arvinas or Johnson & Johnson?

Over the last twelve months, the net margin was -3.5% for Arvinas and 16.2% for Johnson & Johnson, and the operating margin -12.1% and –. Revenue was $275M and $99.3B.

Which is the better investment, Arvinas or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.